Dr. Feng ZHU - Tenured Full Professor

ABOUT THE PRINCIPAL INVESTIGATOR

Dr. Feng ZHU

Distinguished Professor, Tenured Professor, Zhejiang University, China

Highly Cited Researcher, Clarivate, United States

Web of Science h-index: 51 ; Scopus h-index: 51 ; Google Scholar h-index: 59

zhufeng(at)zju.edu.cn (primary), prof.zhufeng(at)gmail.com; +86-571-88208444

PERSONAL DETAILS

Research Interests: Medicinal Chemistry, Drug Design, Target Discovery, Bioinformatics and System Biology

Based on the artificial intelligence and OMIC (proteomics and metabolomics) technologies, we conduct systematical exploration on the druggability and system profile of therapeutic drug targets, develop novel methods and online tools for target discovery, and further study the mechanism underlying the interaction between drugs and their corresponding targets.

Academic Appointments and Educational Qualifications

Current Academic Appointments

Distinguished Professor, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou

Tenured Professor, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou

Honorable Research Mentor, Chu Kochen honors college, Zhejiang University, Hangzhou

Editor-in-Chief, Computers in Biology and Medicine (IF = 7.7), Elsevier, Amsterdam

Associate Editor, Journal of Chemical Information and Modeling (IF = 5.6), American Chemical Society, Washington

Associate Editor, Current Bioinformatics (IF = 4.0), Bentham Science, Sharjah

Member, Committee, Youth League of JiuSan Society, Beijing

President, Committee, BSZP Intelligent Pharmaceutical Sciences, Hangzhou

President, Committee, ZJU Medicial Branch of JiuSan Society, Hangzhou

Vice President, Committee, Zhejiang Provincial Youth Specialty of JiuSan Society, Hangzhou

Secretary-General, Committee, CCS Computational Chemistry, Beijing

Secretary-General, Committee, Western Returned Students' Club of Zhejiang University, Hangzhou

Deputy Secretary-General, Bioinformation and Drug Discovery Committee, Chinese Society for Bioinformatics, Beijing

Standing Committee Member, Artificial Intelligence and Life Sciences Committee, Chinese Society for Bioinformatics, Beijing

Standing Committee Member, Committee, CNPHARS Analytical Pharmacology, Beijing

Standing Committee Member, Youth Committee, CNPHARS Analytical Pharmacology, Beijing

Member, Committee, ZJU Branch of JiuSan Society, Hangzhou

Member, Committee, CSCB Functional Genomics, Beijing

Member, Committee, CCF Task Force on Bioinformatics, Beijing

Member, Committee, Zhejiang Bioinformatics Society, Hangzhou

Honorable Lecturer, Middle School Strategic Partner Group, Zhejiang University, Hangzhou

Previous Academic Appointments and Educational Qualifications

Vice President, Youth Committee, CNPHARS Analytical Pharmacology, Beijing

Member, Committee, CNPHARS Analytical Pharmacology, Beijing

Principle Investigator, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou

Professor, School of Pharmaceutical Sciences, Chongqing University, Chongqing

Principle Investigator, Innovative Drug Research Centre, Chongqing University, Chongqing

Vice President, Committee, Chongqing Bioinformatics Society, Chongqing

Research Fellow, Department of Pharmacy, National University of Singapore, Singapore

Research Associate, Department of Pharmacy, National University of Singapore, Singapore

Research Assistant, Department of Pharmacy, National University of Singapore, Singapore

Doctor of Philosophy, Department of Pharmacy, National University of Singapore, Singapore

Master of Science, Key Laboratory of Applied Optics, Beijing Normal University, Beijing

Bachelor of Science, Department of Physics, Beijing Normal University, Beijing

Honors and Awards

Representative Honors & Awards

Leading Talent of the National High-Level Talent Special Support Plan of China (2020)

Honorable Professor of the Youth International Recruitment Program of China (2014)

Laureate of the Highly Cited Researcher of Clarivate (2023)

Leading Talent of the Science & Technology Nova Program of Chinese MOST (2019)

Corresponding Author of the Publications of Top-100 World-wide Impact of Chinese MOST (2021)

Laureate of the Fund for Distinguished Young Scholars of Zhejiang Province (2021)

Honorable Professor of the High-level Talent Support Plan of Zhejiang Province (2018)

Laureate of the Grand Prize in Natural Science of Bioinformatics Society of Zhejiang Province (Ranked the First, 2023)

Laureate of the 100,000 Top-scientists of Global Author ID Database (2021, 2022)

Laureate of the 100,000 Top-scientists of Stanford University Science-wide Author Database (2020, 2021, 2022)

Laureate of the Best Biology and Biochemistry Scientists of Global Academic Sites Research.com (2022)

Laureate of the Leading Scholar in Social Practice of JiuSan Society (2021)

Laureate of the Top-10 Annual Scientific Advances in Bioinformatics in China of Elsevier Publication Group (2023)

Laureate of the Top Cited Paper Award of Wiley Publication Group (2020)

Supervisor of the Outstanding Doctor Postgraduate of Zhejiang Province (2021)

Supervisor of the Outstanding Master Postgraduate of Zhejiang Province (2020)

Other Honors & Awards

Key Innovative Team Member of the Science & Technology Nova Program of Chinese MOST (2019)

Laureate of the First Class Science & Technology Award of Chongqing Province (Ranked the Fourth, 2019)

Supervisor of the Third Class Challenge Cup Award of Zhejiang Province (2021)

Laureate of the First Class Shihuayu Teaching Scholarship of Zhejiang University (2021)

Laureate of the School-level Teaching Scholarship (2023)

Supervisor of the Jiangzhi Biomedical Award of Zhejiang University (2020)

Supervisor of the Second Class Challenge Cup Award of Zhejiang University (2021)

Laureate of the Third Class Tanglixin Teaching Scholarship of Chongqing University (2014)

Laureate of the Top-10 Annual Scientific Advances of College of Pharmaceutical Sciences in Zhejiang University (2022, 2023)

Laureate of the Annual Outstanding Professor of College of Pharmaceutical Sciences in Zhejiang University (2020)

Laureate of the Annual Outstanding Professor of College of Pharmaceutical Sciences in Zhejiang University (2019)

Educational Reform Projects (PI: Principal Investigator; PP: Project Participant)

2022.10 - (PI, 省部级): IECC Foundation of the Ministry of Education of China (2022-AliC-4-32)

2021.12 - (PI, 省部级): Textbook Construction in 13th Five-Year Plan of Zhejiang Province (2021-135-33)

2021.01 - (PI, 学校级): Postgraduate Education Reform Foundation of China (zyjyjx-grazju-49)

2020.06 - (PI, 学校级): Undergraduate Education Reform Foundation of China (068-484607)

2020.09 - (PI, 学校级): Postgraduate Education Reform Foundation of Zhejiang University (1913039)

Research Grants (PI: Principal Investigator; PP: Project Participant)

Project(s) on Going

2024.01 - (PI, 国家级): National Natural Science Foundation General Program of China (82373790)

2023.01 - (PI, 国家级): National Natural Science Foundation Key Program of China (22220102001)

2021.01 - (PI, 省部级): Fund for Distinguished Young Scholars of Zhejiang Province (LR21H300001)

2020.10 - (PI, 国家级): National Leading Talent Special Support Plan of China (CWR-L-ZJU2020-ZF)

2020.01 - (PI, 国家级): National Natural Science Foundation Collaboration Program of China (U1909208)

Project(s) Completed

2014.06 - (PI, 国家级): Youth International Recruitment Program of China (IRPC-Y-CQU2014-ZF)

2016.08 - (PI, 国家级): National Key Research and Development Program of China (2016YFC0902200)

2018.09 - (PI, 国家级): National Key Research and Development Program of China (2018YFC0910500)

2019.01 - (PI, 国家级): National Natural Science Foundation General Program of China (81872798)

2013.01 - (PI, 国家级): National Natural Science Foundation Youth Program of China (81202459)

2015.12 - (PI, 省部级): Special Fund for Chemical Drug Discovery of Chongqing Province (cstc2015zdcy-ztzx120003)

2020.01 - (PI, 省部级): Key Research and Development Program of Zhejiang Province (2020C03010)

2021.05 - (PI, 省部级): Research Fund for Injury Prevention of Zhejiang Province (181201*194232101)

2012.09 - (PI, 省部级): Natural Science Foundation General Program of Chongqing Province (cstc2012jjA10116)

2021.02 - (PI, 学校级): Fund for Future Digital Healthcare of Alibaba-ZJU Collaboration (ALIZJU202101)

2017.07 - (PI, 学校级): Hundreds-Talents Program of Zhejiang University (ZJU2017070, evaluated as "Excellent")

2012.07 - (PI, 学校级): Hundreds-Talents Program of Chongqing University (0903005203176, evaluated as "Excellent")

2014.06 - (PI, 学校级): Major Fundation for Chongqing University (CDJZR14 46 88 01, evaluated as "Excellent")

2013.01 - (PI, 学校级): Key Fundation for Chongqing University (CQDXWL-2012-Z003, evaluated as "Excellent")

2018.01 - (PI, 学校级): Youth Research Innovation Grant of Zhejiang University (2018QNA7023)

Published Key Textbooks ( front cover of the book)

2023.01 (Undergraduate Textbook) : "AI in Medicine" ISBN 978-7-308-23491-7, Zhejiang University Press

The Unique Feature of This Book:

Key Textbook for the Universities of Zhejiang Province in the 14th Five-Year Plan

2023.06 (Drug Discovery Book) : "Artificial Intelligence and Drug Design" ISBN 978-7-122-42928-5, Chemical Industry Press

The Unique Feature of This Book:

Key Project Supported by Chinese National Publication Foundation (2023)

2023.03 (Undergraduate Textbook) : "Drug Design" ISBN 978-7-04-059211-5, Higher Education Press

The Unique Feature of This Book:

Key Textbook for the Ministry of Industry and Information Technology of China

Key Textbook for the Medical Education of China in the 14th Five-Year Plan

Key Textbook for the National Education of China in the 11th Five-Year Plan

Selected Core Publications (*corresponding author; published cover article; PDF version of paper)

J. B. Fu, Y. Zhang, Y. X. Wang, H. N. Zhang, J. Liu, J. Tang, Q. X. Yang, H. C. Sun, W. Q. Qiu, Y. H. Ma, Z. R. Li, M. Y. Zheng, F. Zhu*. Optimization of metabolomic data processing using NOREVA. Nature Protocols (impact factor of the publication year: 17.021, 生物一区 TOP 期刊). 17(1): 129-151 (2022). PMID: 34952956.

Featured Article:

The Featured Article This Week (1st week of 2022) of Nature Protocols 2022, Download HERE.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.26% in 2023.

Media Coverage & News Report:

Beijing Academy of AI. Dec 31th, 2021.

Chowdera.com. Dec 31th, 2021.

CPS@ZJU. Dec 30th, 2021.

Chinese ZhiHu. Dec 31th, 2021.

DrugAI. Dec 31th, 2021.

eBiotrade. Jan 1th, 2022.

ECHEMI.com. Jan 27th, 2022.

Gene Online. Jan 1th, 2022.

India Education Diary. Jan 28th, 2022.

Mirage News. Jan 27th, 2022.

Neurons AI. Jan 27th, 2022.

NSF@Zhejiang. Jan 24th, 2022.

Tencent Cloud. Jan 1th, 2022.

ZJU Newsroom. Jan 26th, 2022.

Zhejiang University. Dec 30th, 2021.

Y. X. Wang, S. Zhang, F. C. Li, Y. Zhou, Y. Zhang, Z. W. Wang, R. Y. Zhang, J. Zhu, Y. X. Ren, Y. Tan, C. Qin, Y. H. Li, X. X. Li, Y. Z. Chen*, F. Zhu*. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Research (impact factor of the publication year: 16.971, 生物一区 TOP 期刊). 48(D1): 1031-1041 (2020). PMID: 31691823.

Publication of World-wide Reputation:

The Top-100 Chinese Publications of The World-wide Impact (2021).

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.12% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.13% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.15% in 2021.

Media Coverage & News Report:

DrugAI. Jul 2nd, 2020.

Deep Singularity. Jul 3rd, 2020.

F. C. Li, J. Y. Yin, M. K. Lu, M. J. Mou, Z. R. Li, Z. Y. Zeng, Y. Tan, S. S. Wang, X. Y. Chu, H. B. Dai, T. J. Hou, S. Zeng*, Y. Z. Chen*, F. Zhu*. DrugMAP: molecular atlas and pharma-information of all drugs. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(D1): 1288-1299 (2023). PMID: 36243961.

Cover Article:

The Cover Article of Nucleic Acids Res 2023 51(D1), Download the Cover .

Media Coverage & News Report:

CPS@ZJU. Nov 3th, 2022.

eBiotrade. Nov 8th, 2022.

EcoSmart Medicine. Nov 8th, 2022.

NSF@Zhejiang. Nov 22th, 2022.

Zhejiang University. Nov 9th, 2022.

Zhiyun Academic. Nov 16th, 2022.

ZJU Newsroom. Dec 28th, 2022.

Y. Zhang, H. C. Sun, X. C. Lian, J. Tang, F. Zhu*. ANPELA: significantly enhanced quantification tool for cytometry-based single-cell proteomics. Advanced Science (impact factor of the publication year: 17.521, 工程技术一区 TOP 期刊). 10(15): e2207061 (2023). PMID: 36950745.

Cover Article:

The Cover Article of Adv Sci 2023 10(15), Download the Cover .

Y. H. Li, X. X. Li, J. J. Hong, Y. X. Wang, J. B. Fu, H. Yang, C. Y. Yu, F. C. Li, J. Hu, W. W. Xue, Y. Y. Jiang, Y. Z. Chen*, F. Zhu*. Clinical trials, progression-speed differentiating features, and swiftness rule of the innovative targets of first-in-class drugs. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(2): 649-662 (2020). PMID: 30689717.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.36% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.49% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.09% in 2021.

Q. X. Yang, B. Li, J. Tang, X. J. Cui, Y. X. Wang, X. F. Li, J. Hu, Y. Z. Chen, W. W. Xue, Y. Lou, Y. Q. Qiu*, F. Zhu*. Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(3): 1058-1068 (2020). PMID: 31157371.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.29% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.56% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.19% in 2021.

Selected Important Publications (*corresponding author; published cover article; PDF version of paper)

M. J. Mou, Z. Q. Pan, Z. M. Zhou, L. Y. Zheng, H. Y. Zhang, S. Y. Shi, F. C. Li, X. N. Sun, F. Zhu*. A transformer-based ensemble framework for the prediction of protein-protein interaction sites. Research (impact factor of the publication year: 11.016, 综合一区 TOP 期刊). 6: 0240 (2023). PMID: 37771850.

Media Coverage & News Report:

DrugAI. Oct 12th, 2023.

Y. X. Wang, Z. Chen, Z. Q. Pan, S. J. Huang, J. Liu, W. Q. Xia, H. N. Zhang, M. Y. Zheng, H. L. Li, T. J. Hou, F. Zhu*. RNAincoder: a deep learning-based encoder for RNA and RNA-associated interaction. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(W1): W509-W519 (2023). PMID: 37166951.

Y. X. Wang, Z. Q. Pan, M. J. Mou, W. Q. Xia, H. N. Zhang, H. Y. Zhang, J. Liu, L. Y. Zheng, Y. C. Luo, H. Q. Zheng, X. Y. Yu, X. C. Lian, Z. Y. Zeng, Z. R. Li, B. Zhang, M. Y. Zheng, H. L. Li, T. J. Hou, F. Zhu*. A task-specific encoding algorithm for RNAs and RNA-associated interactions based on convolutional autoencoder. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). 51(21): e110 (2023). PMID: 37889083.

Y. Zhou, Y. T. Zhang, D. H. Zhao, X. Y. Yu, X. Y. Shen, Y. Zhou, S. S. Wang, Y. Q. Qiu, Y. Z. Chen*, F. Zhu*. TTD: Therapeutic Target Database describing target druggability information. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). doi: 10.1093/nar/gkad751 (2024). PMID: PMID: 37713619.

L. T. Shen, X. N. Sun, Z. Chen, Y. Guo, Z. Y. Shen, Y. Song, W. X. Xin, H. Y. Ding, X. Y. Ma, W. B. Xu, W. Y. Zhou, J. X. Che, L. L. Tan, L. S. Chen, S. Q. Chen, X. W. Dong*, L. Fang*, F. Zhu*. ADCdb: the database of antibody-drug conjugates. Nucleic Acids Research (当年影响因子: 19.160, 生物二区 TOP 期刊). accepted: NAR-02369-Data-E-2023 (2024). PMID: 37831118.

Y. T. Zhang, Y. Zhou, Y. Zhou, X. Y. Yu, X. Y. Shen, Y. F. Hong, Y. X. Zhang, S. S. Wang, M. J. Mou, J. S. Zhang, L. Tao, J. Q. Gao, Y. Q. Qiu*, Y. Z. Chen*, F. Zhu*. TheMarker: a comprehensive database of therapeutic biomarkers. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02063-Data-E-2023 (2024). PMID: 37850638.

X. C. Lian, Y. T. Zhang, Y. Zhou, X. N. Sun, S. J. Huang, H. B. Dai*, L. Y. Han*, F. Zhu*. SingPro: a knowledge base providing single-cell proteomic data. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02157-Data-E-2023 (2024). PMID: 37819028.

J. Y. Yin, Z. Chen, N. X. You, F. C. Li, H. Y. Zhang, J. Xue, H. Ma, Q. W. Zhao, L. S. Yu*, S. Zeng*, F. Zhu*. VARIDT 3.0: the phenotypic and regulatory variability of drug transporter. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02109-Data-E-2023 (2024). PMID: 37819041.

Y. Zhang, X. G. Liu, F. C. Li, J. Y. Yin, H. Yang, X. D. Li, X. Y. Liu, X. Chai, T. L. Niu, S. Zeng*, Q. Z. Jia*, F. Zhu*. INTEDE 2.0: the metabolic roadmap of drugs. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). NAR-02756-Data-E-2023 (2023). PMID: 37930837.

Y. Zhang, H. C. Sun, W. Zhang, T. T. Fu, S. J. Huang, M. J. Mou, J. S. Zhang, J. Q. Gao, Y. C. Ge*, Q. X. Yang*, F. Zhu*. CellSTAR: a comprehensive resource for single-cell transcriptomic annotation. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物二区 TOP 期刊). accepted: NAR-02385-Data-E-2023 (2024). PMID: 37855686.

Q. X. Yang, Y. X. Wang, Y. Zhang, F. C. Li, W. Q. Xia, Y. Zhou, Y. Q. Qiu, H. L. Li, F. Zhu*. NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data. Nucleic Acids Research (impact factor of the publication year: 16.971, 生物一区 TOP 期刊). 48(W1): 436-448 (2020). PMID: 32324219.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.87% in 2023.

The Percentile in Subject Area shown in InCites™ was 1.60% in 2022.

Media Coverage & News Report:

DrugAI. Jan 4th, 2021.

X. N. Sun, Y. T. Zhang, H. Y. Li, Y. Zhou, S. Y. Shi, Z. Chen, X. He, H. Y. Zhang, F. C. Li, J. Y. Yin, M. J. Mou, Y. Z. Wang, Y. Q. Qiu, F. Zhu*. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(D1): 1263-1275 (2023). PMID: 36243960.

Media Coverage & News Report:

Antpedia. Apr 17th, 2023.

AutophagyAdvances. Mar 3th, 2023.

bilibili. Fer 3th, 2023.

CPS@ZJU. Mar 4th, 2023.

CSDN. Apr 12th, 2023.

eBiotrade. Mar 3th, 2023.

iBioinformatics. Apr 14th, 2023.

JinriArticle. Mar 3th, 2023.

SciRes. Apr 15th, 2023.

Sohu. Apr 25th, 2023.

Zhihu. Apr 25th, 2023.

T. T. Fu, F. C. Li, Y. Zhang, J. Y. Yin, W. Q. Qiu, X. D. Li, X. G. Liu, W. W. Xin, C. Z. Wang, L. S. Yu, J. Q. Gao, Q. C. Zheng*, S. Zeng*, F. Zhu*. VARIDT 2.0: structural variability of drug transporter. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 50(D1): 1417-1431 (2022). PMID: 34747471.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 1.48% in 2023.

Media Coverage & News Report:

CPS@ZJU. Nov 10th, 2021.

DrugAI. Nov 11th, 2021.

NSF@Zhejiang. Dec 22th, 2021.

Zhejiang University. Nov 9th, 2021.

J. Y. Yin, F. C. Li, Y. Zhou, M. J. Mou, Y. J. Lu, K. L. Chen, J. Xue, Y. C. Luo, J. B. Fu, X. He, J. Q. Gao, S. Zeng*, L. S. Yu*, F. Zhu*. INTEDE: interactome of drug-metabolizing enzymes. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 49(D1): 1233-1243 (2021). PMID: 33045737.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 1.01% in 2023.

The Percentile in Subject Area shown in InCites™ was 1.12% in 2022.

Media Coverage & News Report:

DrugAI. Jan 11th, 2021.

CPS@ZJU. Jan 15th, 2021.

Intelli Bioinform. Jan 12th, 2021.

B. Li, J. Tang, Q. X. Yang, S. Li, X. J. Cui, Y. H. Li, Y. Z. Chen, W. W. Xue, X. F. Li, F. Zhu*. NOREVA: normalization and evaluation of MS-based metabolomics data. Nucleic Acids Research (impact factor of the publication year: 10.162, 生物一区 TOP 期刊). 45(W1): 162-170 (2017). PMID: 28525573.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.60% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.77% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.71% in 2021.

The Percentile in Subject Area shown in InCites™ was 0.75% in 2020.

The Percentile in Subject Area shown in InCites™ was 1.27% in 2019.

The Percentile in Subject Area shown in InCites™ was 2.98% in 2018.

Highlights by Experts in Subject Area:

Introduced by OMICTOOLS as "provided valuable guidance to the selection of suitable algorithm in metabolomics".

Discussed in StackExchange as "works fine" and "corrections for batches without QC options".

Y. H. Li, C. Y. Yu, X. X. Li, P. Zhang, J. Tang, Q. X. Yang, T. T. Fu, X. Y. Zhang, X. J. Cui, G. Tu, Y. Zhang, S. Li, F. Y. Yang, Q. Sun, C. Qin, X. Zeng, Z. Chen, Y. Z. Chen*, F. Zhu*. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Research (impact factor of the publication year: 11.561, 生物一区 TOP 期刊). 46(D1): 1121-1127 (2018). PMID: 29140520.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.28% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.21% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.15% in 2021.

The Percentile in Subject Area shown in InCites™ was 0.14% in 2020.

The Percentile in Subject Area shown in InCites™ was 0.16% in 2019.

Highlights by Experts in Subject Area:

Introduced by OMICTOOLS as "useful for facilitating patient focused research, discovery and clinical investigations of the targeted therapeutics".

J. Y. Yin, W. Sun, F. C. Li, J. J. Hong, X. X. Li, Y. Zhou, Y. J. Lu, M. Z. Liu, X. Zhang, N. Chen, X. P. Jin, J. Xue, S. Zeng*, L. S. Yu*, F. Zhu*. VARIDT 1.0: variability of drug transporter database. Nucleic Acids Research (impact factor of the publication year: 16.971, 生物一区 TOP 期刊). 48(D1): 1042-1050 (2020). PMID: 31495872.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.81% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.96% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.33% in 2021.

Media Coverage & News Report:

DrugAI. Jul 2nd, 2020.

Deep Singularity. Jul 3rd, 2020.

K. Amahong, W. Zhang, Y. Zhou, S. Zhang, J. Y. Yin, F. C. Li, H. Q. Xu, T. C, Yan, Z. X. Yue, Y. H. Liu, T. J. Hou, Y. Q. Qiu, L. Tao*, L. Y. Han*, F. Zhu*. CovInter: interaction data between coronavirus RNAs and host proteins. Nucleic Acids Research (impact factor of the publication year: 19.160, 生物一区 TOP 期刊). 51(D1): 546-556 (2023). PMID: 36200814.

Media Coverage & News Report:

CPS@ZJU. Oct 14th, 2022.

eBiotrade. Oct 25th, 2022.

ECHEMI.com. Oct 31th, 2022.

FMP@ZJU. Oct 14th, 2022.

Genome Web. Oct 10th, 2022.

Gen Online. Oct 25th, 2022.

Innovative Hangzhou. Oct 20th, 2022.

IPM-GBA. Nov 9th, 2022.

India Education Diary. Nov 4th, 2022.

LIFE BOAT. Nov 9th, 2022.

Mirage News. Nov 2th, 2022.

Net of Instrument Info. Oct 18th, 2022.

PHYS.ORG. Nov 2th, 2022.

STA@ZJU. Oct 24th, 2022.

Quietly Positive. Nov 2th, 2022.

Science Week. Nov 2th, 2022.

ZJU Newsroom. Nov 2th, 2022.

Zhejiang University. Oct 17th, 2022.

M. K. Lu, J. Y. Yin, Q. Zhu, G. L. Lin, M. J. Mou, F. Y. Liu, Z. Q. Pan, N. X. You, X. C. Lian, F. C. Li, H. N. Zhang, L. Y. Zheng, W. Zhang, H. Y. Zhang, Z. H. Shen, Z. Gu, H. L. Li*, F. Zhu*. Artificial intelligence in pharmaceutical sciences. Engineering (impact factor of the publication year: 12.834, 工程技术一区 TOP 期刊). doi: 10.1016/j.eng.2023.01.014 (2023). PMID: XXXXXXXX.

H. N. Zhang, M. K. Lu, G. L. Lin, L. Y. Zheng, W. Zhang, Z. J. Xu, F. Zhu*. SoCube: an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物二区 TOP 期刊). 24(3): bbad104 (2023). PMID: 36941114.

H. Y. Zhang, Y. X. Wang, Z. Q. Pan, X. N. Sun, M. J. Mou, B. Zhang, Z. R. Li, H. L. Li*, F. Zhu*. ncRNAInter: a novel strategy based on graph neural network to discover interactions between lncRNA and miRNA. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(6): bbac411 (2022). PMID: 36198065.

J. J. Hong, Y. C. Luo, M. J. Mou, J. B. Fu, Y. Zhang, W. W. Xue, T. Xie, L. Tao*, Y. Lou*, F. Zhu*. Convolutional neural network-based annotation of bacterial type IV secretion system effectors with enhanced accuracy and reduced false discovery. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(5): 1825-1836 (2020). PMID: 31860715.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.73% in 2023.

The Percentile in Subject Area shown in InCites™ was 1.18% in 2022.

J. J. Hong, Y. C. Luo, Y. Zhang, J. B. Ying, W. W. Xue, T. Xie, L. Tao*, F. Zhu*. Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(4): 1437-1447 (2020). PMID: 31504150.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.58% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.94% in 2022.

J. Tang, J. B. Fu, Y. X. Wang, B. Li, Y. H. Li, Q. X. Yang, X. J. Cui, J. J. Hong, X. F. Li, Y. Z. Chen, W. W. Xue, F. Zhu*. ANPELA: analysis and performance-assessment of the label-free quantification workflow for metaproteomic studies. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(2): 621-636 (2020). PMID: 30649171.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.30% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.20% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.05% in 2021.

F. C. Li, Y. Zhou, Y. Zhang, J. Y. Yin, Y. Q. Qiu, J. Q. Gao, F. Zhu*. POSREG: proteomic signature discovered by simultaneously optimizing its reproducibility and generalizability. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(2): bbac040 (2022). PMID: 35183059.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.06% in 2023.

F. C. Li, J. Y. Yin, M. K. Lu, Q. X. Yang, Z. Y. Zeng, B. Zhang, Z. R. Li, Y. Q. Qiu, H. B. Dai, Y. Z. Chen*, F. Zhu*. ConSIG: consistent discovery of molecular signature from OMIC data. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(4): bbac253 (2022). PMID: 35758241.

Q. X. Yang, J. J. Hong, Y. Li, W. W. Xue, S. Li*, H. Yang*, F. Zhu*. A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies. Briefings in Bioinformatics (impact factor of the publication year: 11.622, 生物一区 TOP 期刊). 21(6): 2142-2152 (2020). PMID: 31776543.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 2.30% in 2023.

The Percentile in Subject Area shown in InCites™ was 2.69% in 2022.

S. Zhang, K. Amahong, C. Y. Zhang, F. C. Li, J. Q. Gao, Y. Q. Qiu*, F. Zhu*. RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection. Briefings in Bioinformatics (impact factor of the publication year: 13.994, 生物一区 TOP 期刊). 23(1): bbab397 (2022). PMID: 34585235.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.12% in 2023.

S. Zhang, F. Zhu*. Comment on microRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs (impact factor of the publication year: 11.431, 医学二区 TOP 期刊). 81(14): 1691-1692 (2021). PMID: 34453690.

Q. X. Yang*, Y. G. Gong, F. Zhu*. Critical assessment of the biomarker discovery and classification methods for multiclass metabolomics. Analytical Chemistry (impact factor of the publication year: 8.008, 化学一区 TOP 期刊). 95(13): 5542-5552 (2023). PMID: 36944135.

Y. X. Wang, F. C. Li, Y, Zhang, Y. Zhou, Y. Tan, Y. Z. Chen*, F. Zhu*. Databases for the targeted COVID-19 therapeutics. British Journal of Pharmacology (impact factor of the publication year: 7.730, 医学二区 TOP 期刊). 177(21): 4999-5001 (2020). PMID: 32845521.

Q. X. Yang, Y. X. Wang, F. C. Li, S. Zhang, Y. C. Luo, Y. Li, J. Tang, B. Li, Y. Z. Chen, W. W. Xue, F. Zhu*. Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility. CNS Neuroscience & Therapeutics (impact factor of the publication year: 7.035, 医学一区 TOP 期刊). 25(9): 1054-1063 (2019). PMID: 31350824.

Cover Article:

The Cover Article of CNS Neurosci Ther 2019 25(9), Download the Cover .

Z. J. Han, W. W. Xue, L. Tao, F. Zhu*. Identification of novel immune-relevant drug target genes for alzheimer's disease by combining ontology inference with network analysis. CNS Neuroscience & Therapeutics (impact factor of the publication year: 7.035, 医学一区 TOP 期刊). 24(12): 1253-1263 (2018). PMID: 30106219.

Honors and Awards:

Wiley Top Cited Paper Award (2020).
Cover Article:

The Cover Article of CNS Neurosci Ther 2018 24(12), Download the Cover .

W. Q. Xia, L. Y. Zheng, J. B. Fang, F. C. Li, Y. Zhou, Z. Y. Zeng, B. Zhang, Z. R. Li, H. L. Li*, F. Zhu*. PFmulDL: a novel strategy enabling multi-class and multi-label protein function annotation by integrating diverse deep learning methods. Computers in Biology and Medicine (impact factor of the publication year: 6.698, 工程技术二区期刊). 145: 105465 (2022). PMID: 35366467.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.40% in 2023.

S. Zhang, K. Amahong, Y. T. Zhang, X. P. Hu, S. J. Huang, M. K. Lu, Z. Y. Zeng, Z. R. Li, B. Zhang, Y. Q. Qiu, H. B. Dai, J. Q. Gao, F. Zhu*. RNAenrich: a web server for non-coding RNA enrichment. Bioinformatics (impact factor of the publication year: 6.931, 生物二区 TOP 期刊). 39(7): btad421 (2023). PMID: 37399102.

C. F. Xu, J. T. Huang, Y. Q. Gao, W. X. Zhao, Y. Q. Shen, F. H. Luo, G. Yu, F. Zhu*, Y. Ni*. OBMeta: a comprehensive web server to analyze and validate gut microbial features and biomarkers for obesity-associated metabolic diseases. Bioinformatics (impact factor of the publication year: 6.931, 生物二区 TOP 期刊). accepted: BIOINF-2023-1043 (2023). PMID: XXXXXXXX.

M. J. Mou, Z. Q. Pan, M. K. Lu, H. C. Sun, Y. X. Wang, Y. C. Luo, F. Zhu*. Application of machine learning in spatial proteomics. Journal of Chemical Information and Modeling (impact factor of the publication year: 6.162, 化学二区期刊). 62(23): 5875–5895 (2022). PMID: 36378082.

Cover Article:

The Cover Article of J Chem Inf Model 2022 62(23), Download the Cover .

T. T. Fu, G. Tu, M. Ping, G. X. Zheng, F. Y. Yang, J. Y. Yang, Y. Zhang, X. J. Yao, W. W. Xue*, F. Zhu*. Subtype selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors. Acta Pharmacologica Sinica (impact factor of the publication year: 6.150, 医学一区 TOP 期刊). 42(8): 1354-1367 (2021). PMID: 33122823.

J. Tang, J. B. Fu, Y. X. Wang, Y. C. Luo, Q. X. Yang, B. Li, G. Tu, J. J. Hong, X. J. Cui, Y. Z. Chen, L. X. Yao, W. W. Xue, F. Zhu*. Simultaneous improvement in the precision, accuracy and robustness of label-free proteome quantification by optimizing data manipulation chains. Molecular & Cellular Proteomics (impact factor of the publication year: 7.381, 生物一区 TOP 期刊). 18(8): 1683-1699 (2019). PMID: 31097671.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.87% in 2023.

The Percentile in Subject Area shown in InCites™ was 1.12% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.81% in 2021.

The Percentile in Subject Area shown in InCites™ was 0.57% in 2020.

F. C. Li, Y. Zhou, X. Y. Zhang, J. Tang, Q. X. Yang, Y. Zhang, Y. C. Luo, J. Hu*, W. W. Xue, Y. Q. Qiu, Q. J. He, B. Yang, F. Zhu*. SSizer: determining the sample sufficiency for comparative biological study. Journal of Molecular Biology (impact factor of the publication year: 5.067, 生物二区 TOP 期刊). 432(11): 3411-3421 (2020). PMID: 32044343.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 2.93% in 2023.

Y. Zhang, J. B. Ying, J. J. Hong, F. C. Li, T. T. Fu, F. Y. Yang, G. X. Zheng, X. J. Yao, Y. Lou, Y. Q. Qiu, W. W. Xue*, F. Zhu*. How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from Trichostatin A enantiomers based on molecular dynamics. ACS Chemical Neuroscience (impact factor of the publication year: 4.211, 化学二区 TOP 期刊). 10(5): 2467-2480 (2019). PMID: 30784262.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.48% in 2023.

The Percentile in Subject Area shown in InCites™ was 1.85% in 2022.

The Percentile in Subject Area shown in InCites™ was 1.19% in 2021.

The Percentile in Subject Area shown in InCites™ was 0.74% in 2020.

Cover Article:

The Cover Article of ACS Chem Neurosci 2019 10(5), Download the Cover .

W. W. Xue, F. Y. Yang, P. P. Wang, G. X. Zheng, Y. Z. Chen, X. J. Yao, F. Zhu*. What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation. ACS Chemical Neuroscience (impact factor of the publication year: 4.211, 化学二区 TOP 期刊). 9(5): 1128-1140 (2018). PMID: 29300091.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.11% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.18% in 2022.

The Percentile in Subject Area shown in InCites™ was 0.14% in 2021.

The Percentile in Subject Area shown in InCites™ was 0.21% in 2020.

The Percentile in Subject Area shown in InCites™ was 0.29% in 2019.

W. W. Xue, T. T. Fu, S. Z. Deng, F. Y. Yang, J. Y. Yang, F. Zhu*. Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram. ACS Chemical Neuroscience (impact factor of the publication year: 5.780, 医学二区期刊). 13(3): 340-351 (2022). PMID: 35041375.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.05% in 2023.

The Percentile in Subject Area shown in InCites™ was 0.09% in 2022.

F. Y. Yang, G. X. Zheng, T. T. Fu, X. F. Li, G. Tu, Y. H. Li, X. J. Yao, W. W. Xue*, F. Zhu*. Prediction of binding mode and resistance profile for dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase associated ribonuclease H. Physical Chemistry Chemical Physics (impact factor of the publication year: 4.123, 化学二区 TOP 期刊). 20(37): 23873-23884 (2018). PMID: 29947629.

Back Cover Article:

The Back Cover Article of Phys Chem Chem Phys 2018 20(37), Download the Cover .

Q. X. Yang, B. Li, S. J. Chen, J. Tang, Y. H. Li, Y. Li, S. Zhang, C. Shi, Y. Zhang, M. J. Mou, W. W. Xue*, F. Zhu*. MMEASE: online meta-analysis of metabolomic data by enhanced metabolite annotation, marker selection and enrichment analysis. Journal of Proteomics (impact factor of the publication year: 4.044, 生物二区期刊). 232: 104023 (2021). PMID: 33130111.

ESI Highly Cited Paper:

The Percentile in Subject Area shown in InCites™ was 0.69% in 2023.

The Percentile in Subject Area shown in InCites™ was 2.51% in 2022.

Licensed Patents and Copyrights

F. Zhu, X. N. Sun, S. Zhang, M. J. Mou, et al. Software Copyright 2023SR0736962 approved by the National NCAC of China.
A Software Tool for Metabolite and Protein Regulatory Network Analysis (2023)

F. Zhu, M. J. Mou, X. N. Sun, C. Y. Zhang. Software Copyright 2023SR0682069 approved by the National NCAC of China.
A Software Tool for Analyzing Biological Activities of Drug Inactive Ingredients (2023)

F. Zhu, X. N. Sun, Y. T. Zhang, H. Y. Li, Y. Zhou. Software Copyright 2023SR0682068 approved by the National NCAC of China.
A Software Tool for Comprehensive Drug Resistance Analysis (2023)

F. Zhu, F. C. Li, H. C. Sun, J. Y. Yin. Software Copyright 2022SR1374536 approved by the National NCAC of China.
A Software Tool for Metabolomics-based Quantitative Analysis of Large-scale and Long-term Microbiota Study (2022)

F. Zhu, J. Y. Yin, F. C. Li, Y. Zhou, M. J. Mou. Software Copyright 2022SR1374538 approved by the National NCAC of China.
A Software Tool for Interaction Analysis of Drug-metabolizing Enzyme Intergroup (2022)

F. Zhu, F. C. Li, J. Y. Yin, M. K. Lu, M. J. Mou. Software Copyright 2022SR1374548 approved by the National NCAC of China.
A Software Tool for Molecular Profiling of Drug Interactions (2022)

F. Zhu, F. C. Li, J. Y. Yin, M. K. Lu, Q. X. Yang. Software Copyright 2022SR1374537 approved by the National NCAC of China.
A Software Tool for Stable Identification of Molecular Features based on OMICS Data (2022)

F. Zhu, F. C. Li, J. Y. Yin, Y. Zhou, Y. Zhang. Software Copyright 2022SR1374547 approved by the National NCAC of China.
A Software Tool for High Precision Identification of Biomarkers Based on Proteomics Technology (2022)

F. Zhu, M. J. Mou, J. Tang, X. N. Sun. Software Copyright 2022SR1096571 approved by the National NCAC of China.
A Software Tool for Analyzing Host Regulatory Factors of Human Microbiota (2022)

F. Zhu, M. J. Mou, J. Tang, Y. X. Wang, et al. Software Copyright 2021SR0027303 approved by the National NCAC of China.
A Software Tool for Selecting Metaproteomic Features Based on Performance Assessment (2021)

F. Zhu, J. Y. Yin, F. C. Li, X. X. Li, et al. Software Copyright 2021SR0822567 approved by the National NCAC of China.
A Software Tool for Constructing Phylogenetic Tree Describing the Homology among Drug Transporters (2021)

F. Zhu, F. C. Li, Y. Zhou, X. Y. Zhang. Software Copyright 2021SR0826823 approved by the National NCAC of China.
A Software Tool for Determining Sample Sufficiency for Comparative Biological Study (2021)

F. Zhu, S. Zeng, J. Y. Yin, F. C. Li. Software Copyright 2020SR0275172 approved by the National NCAC of China.
A Software Tool for Analyzing the Interplay among the Variabilities of Drug Transporters (2020)

F. Zhu, Y. X. Wang, Y. Z. Chen, S. Zhang, et al. Software Copyright 2020SR0526446 approved by the National NCAC of China.
A Software Tool for Integrating the Epigenetics with the Protein-Protein Interactions of Drug Target (2020)

F. Zhu, Y. X. Wang, S. Zhang, F. C. Li, et al. Software Copyright 2020SR0527384 approved by the National NCAC of China.
A Software Tool for Strictly Validating the Primary Drug Target and Conducting Network Analysis (2020)

F. Zhu, Y. X. Wang, S. Zhang, F. C. Li, et al. Software Copyright 2020SR0528155 approved by the National NCAC of China.
A Software Tool for Strictly Identifying the Primary Therapeutic Target of the Drugs in Clinical Trial (2020)

F. Zhu, J. J. Hong, J. Hu, L. Tao. Software Copyright 2020SR0274064 approved by the National NCAC of China.
A Software Tool for Discovering the Bacterial Type-IV Secreting System Effector Protein (2019)

F. Zhu, J. Tang, J. B. Fu, Y. X. Wang. Software Copyright 2020SR0274135 approved by the National NCAC of China.
A Software Tool for Assessing Label-free Proteome Quantification from Multiple Perspectives (2019)

F. Zhu, F. C. Li, S. Zhang, Y. X. Wang, et al. Software Copyright 2020SR0525443 approved by the National NCAC of China.
A Software Tool for Discovering the Novel Drug Scaffold Based on Biomarker Identification (2019)

F. Zhu, F. C. Li, S. Zhang, Y. X. Wang, et al. Software Copyright 2020SR0528147 approved by the National NCAC of China.
A Software Tool for Identifying the Tissue-Specific Distribution Pattern of Therapeutic Target (2018)

F. Zhu, Q. X. Yang, B. Li, Y. X. Wang. Software Copyright 2020SR0275177 approved by the National NCAC of China.
A Software Tool for Evaluating Mass-spectrometry-based Metabolomic Data from Multiple Perspectives (2017)

F. Zhu, S. Zhang, F. C. Li, Y. X. Wang, et al. Software Copyright 2020SR0528618 approved by the National NCAC of China.
A Software Tool for Associating the Disease-Relevant Signaling Pathway with Therapeutic Target (2016)

Hosted Conference and Symposium

President of the Organizing Committee

F. Zhu is the Chair of the Organizing Committee for the 4th Worldwide Chinese Computational Biology Conference. Zhejiang University, Hangzhou, P. R. China (2022).

F. Zhu is the Chair of the Organizing Committee for the 11st Asia Hub for e-Drug Discovery. Zhejiang University, Hangzhou, P. R. China (2021).

F. Zhu is the Chair of the Organizing Committee for the 2nd Symposium on Bioinformatics and Drug Design. Chongqing University, Chongqing, P. R. China (2019).

Member of the Academic Committee

F. Zhu is the Member of the Academic Committee for the 4th Worldwide Chinese Computational Biology Conference. Zhejiang University, Hangzhou, P. R. China (2022).

F. Zhu is the Member of the Academic Committee for the 11st Asia Hub for e-Drug Discovery. Zhejiang University, Hangzhou, P. R. China (2021).

F. Zhu is the Member of the Academic Committee for the 16th National Symposium of Computer & Computational Chemistry. Jilin University, Changchun, P. R. China (2021).

F. Zhu is the Member of the Academic Committee for the 15th National Symposium of Computer & Computational Chemistry. Fudan University, Shanghai, P. R. China (2019).

F. Zhu is the Member of the Academic Committee for the 14th National Symposium of Computer & Computational Chemistry. Nanjing University, Nanjing, P. R. China (2017).

F. Zhu is the Member of the Academic Committee for The Second CCF Bioinformatics Conference (CBC-2017). Central South University, Changsha, P. R. China (2017).

F. Zhu is the Member of the Academic Committee for the 2nd Symposium on Bioinformatics and Drug Design. Chongqing University, Chongqing, P. R. China (2019).

F. Zhu is the Member of the Academic Committee for the 13th National Symposium of Computer & Computational Chemistry. Sun Yat-sen University, Guangzhou, P. R. China (2015).

Symposium Chairman or Organizing Committee Member

F. Zhu is the Chairman of the Symposium II (chemometrics and life science) for the 16th National Symposium of Computer & Computational Chemistry. Jilin University, Changchun, P. R. China (2021).

F. Zhu is the Chairman of the Symposium IV (precision drug design and precision medicine) for the 15th National Symposium of Computer & Computational Chemistry. Fudan University, Shanghai, P. R. China (2019).

F. Zhu is the Chairman of the Symposium II (OMIC big data and medical application) for the Fourth CCF Bioinformatics Conference. South China University of Technology, Guangzhou, P. R. China (2019).

F. Zhu is the Member of the Academic Committee for the Fourth CCF Bioinformatics Conference. South China University of Technology, Guangzhou, P. R. China (2019).

F. Zhu is the Vice-chairman of the Symposium 24 Session-4 for the 31st Academic Annual Conference of the Chinese Chemical Society. Zhejiang University, Hangzhou, P. R. China (2018).

F. Zhu is the Chairman of the Symposium IV Session -7 for Asian Federation for Pharmaceutical Sciences Conference 2017. Xiamen University, Xiamen, P. R. China (2017).

F. Zhu is the Chairman of the sub-conference 103 (multi-target and protein-protein interaction) for BIT’s 6th Annual International Congress of Medichem-2016 (ICM-2016). China Pharmaceutical University, Nanjing, P. R. China (2016).

F. Zhu is the Vice-chairman of the 6th theme (study on drug transporter and PK/PD) for BIT’s 6th Annual International Congress of Medichem-2016 (ICM-2016). China Pharmaceutical University, Nanjing, P. R. China (2016).

F. Zhu is the Member of the Organizing Committee for International Symposium on Natural Product Synthesis and Innovative Process Methods for Drug Manufacture. Chongqing University, Chongqing, P. R. China (2012).

Invited Speaker of International/Domestic Conference

Keynote Speaker

Strategy Seminar on Chemistry Division of the National Natural Science Foundation of China & 2021 Annual National Computational Toxicology Conference of China. Yan'an University, Yanan, China (2021)

2020 Annual Conference of Digitization in Medical Administration and Artificial Intelligence in Drug Discovery. Zhejiang Medical Association, Hangzhou, China (2021)

2020 Annal Symposium on Translational Medicine, Bioinformatics and Genomics/Proteomics/Metabolomics-based Technology. Chongqing Medical University, Chongqing, China (2020)

2019 Forum of Intelligent Development of Traditional Chinese Medicine. China Information Association of Traditional Chinese Medicine, Shanghai, China (2019)

1st West Lake Clinical Research and Evaluation Conference and Annual Conference of the Clinical Trial Committee of Zhejiang Pharmaceutical Association. The First Affiliated Hospital, Zhejiang University, Hangzhou, China (2018)

11th China-Japan Symposium on Molecular Drug Design and Development. Zhejiang University and Peking Union Medical College, Chinese Academy of Medical Sciences, Shaoxing, China (2018)

2017 Symposium on Pharmaceutical Chemistry of the Yangtze River Delta Metropolitan Region. Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei, China (2017)

Invited Speaker

The PacifiChem 2021 Symposium. International Chemical Congress of Pacific Basin Societies, Hawaii, USA (2021)

The AHeDD2019/IPAB2019 Joint Symposium. Tokyo Institute of Technology, Kawasaki, Japan (2019)

15th National Symposium of Computer & Computational Chemistry. Fudan University, Shanghai, China (2019)

4th China Analytical Pharmacology Conference. Shenyang Pharmaceutical University, Shenyang, China (2019)

Computational Drug Discovery and ACM Chinese Council. Central South University, Changsha, China (2019)

CPA-EFMC International Symposium on Medicinal Chemistry. Sichuan University, Chengdu, China (2019)

Jiangsu-Zhejiang International Symposium of Bioinformatics. Jiangnan University, Wuxi, China (2019)

3rd Conference for Analytical Pharmacology of CNPHARS. Zunyi Medical University, Zuiyi, China (2018)

10th National Symposium of Genetics Society of China. Nanjing Agricultural University, Nanjing, China (2018)

14th Symposium of the CPA Youth Pharmacologist. Chinese Pharmaceutical Association, Hangzhou, China (2018)

2nd Worldwide Computational Biology and Molecular Simulation Conference. Sun Yat-sen University, Guangzhou, China (2018)

31st Academic Annual Conference of the Chinese Chemical Society. Zhejiang University, Hangzhou, China (2018)

Asian Federation for Pharmaceutical Sciences Conference 2017. Xiamen University, Xiamen, China (2017)

14th National Symposium of Computer & Computational Chemistry. Nanjing University, Nanjing, China (2017)

5th Academic Forum for Postgraduates. Sichuan University, Chengdu, China (2017)

2nd Conference on Innovative Drug Research and Application. Nanjing Biotech and Pharmaceutical Valley, Nanjing, China (2017)

Bioinformatics and Intelligent Information Processing Conference. Shanghai Jiao Tong University, Shanghai, China (2017)

Fifth Young Scholars Forum for Interdisciplinary Researches. Chinese Academy of Sciences, Beijing, China (2017)

2017 (the second) Conference on Precision and Future Medicine. Zhejiang University, Hangzhou, China (2017)

China Society of Biotechnology Young Scientists Forum II. South China University of Technology, Guangzhou, China (2017)

2016 Symposium of Guanghua Young Distinguished Scholars. Fudan University, Shanghai, China (2016)

BIT’s 6th Annual International Congress of Medichem-2016. China Pharmaceutical University, Nanjing, China (2016)

1st International Symposium on Targeted Therapeutics. Chongqing University of Arts and Sciences, Chongqing, China (2016)

4th International Conference on Molecular Simulation. Shanghai Jiao Tong University, Shanghai, China (2016)

7th National Conference on Bioinformatics. University of Electronic Science and Technology of China, Chengdu, China (2016)

2016 Conference on Precision Medicine. Xian Jiaotong University, Xian, China (2016)

12th Sino-US Chemistry Professors Conference. Sun Yat-sen University, Guangzhou, China (2016)

2016 Symposium of International Young Distinguished Scholars. Tongji University, Shanghai, China (2016)

2nd Symposium on Bioinformatics and Drug Design. Chongqing University, Chongqing, China (2016)

2016 Conference on Bioinformatics and Intelligent Information Processing. Jilin University, Jilin, China (2016)

30th Academic Annual Conference of the Chinese Chemical Society. Dalian University of Technology, Dalian, China (2016)

2016 Academic Salon of Shanghai Society for Bioinformatics. Fudan University, Shanghai, China (2016)

2016 Symposium of Big Data and Precision Biomedical Informatics. Shanghai Jiao Tong University, Shanghai, China (2016)

13th National Symposium of Computer & Computational Chemistry. Sun Yat-sen University, Guangzhou, China (2015)

6th International Conference of Molecular Simulation. China Pharmaceutical University, Nanjing, China (2012)

Reviewer of Esteemed Journals (12 Representative Journals)

Nucleic Acids Res (IF = 19.160); Med Res Rev (IF = 12.944); Br J Pharmacol (IF = 8.739);
Nat Protoc (IF = 17.021); Brief Bioinform (IF = 13.994); Bioinformatics (IF = 6.931);
Proc Natl Acad Sci U S A (IF = 12.779); Anal Chem (IF = 8.008); Mol Pharmaceut (IF = 5.364);
J Med Chem (IF = 8.039); Pharmacol Res (IF = 10.334); J Chem Inf Model (IF = 6.162)

IDRB: Innovative Drug Research and Bioinformatics Group

All rights are reserved by: Innovative Drug Research and Bioinformatics Group (IDRB)
College of Pharmaceutical Sciences, Zhejiang University
Hangzhou, P.R. China, 310058.
Contact number: (86 - 571)88208444
ICP ID: 浙ICP备18036997号-1

Last Update: